View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Another Delen Private Bank acquisition in the Netherlands. Ahold Delhaize: Peer Albertsons FY24/25 results. ASML: 1Q25 results; already weaker ahead of the tariffs. Barco: Calm before the storm. Heineken: In the hold. Melexis: Partial move to China. Staffing sector: Hays' 3Q24/25 trading update; in line. Vopak: New industrial terminal or energy transition facility? WDP: €60m investment with KDL

Guy Sips ... (+6)
  • Guy Sips
  • Kristof Samoy
  • Livio Luyten
  • Thibault Leneeuw
  • Wim Hoste
  • Wim Lewi
Livio Luyten
  • Livio Luyten

Ackermans & van Haaren Delen Private Bank acquires Dutch Servatus Verm...

Delen Private Bank has reached an agreement with the shareholders of Servatus Vermogensmanagement to acquire 100% of the company. This acquisition aligns with Delen Private Bank's growth strategy in the Netherlands, aiming to strengthen its position as an independent player in the Dutch private banking market. Servatus manages more than €700m in assets – post transaction completion, the private banking division's Dutch AuM will cross €4.0b. This marks a significant rise from ~€1.4m at FY23-end. ...

 PRESS RELEASE

Galapagos Announces Departure of Thad Huston, CFO and COO, as of Augus...

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced the departure of its CFO and COO, Thad Huston, effective as of August 1, 2025. Mr. Huston has decided to leave the company and return to the U.S. for personal and professional reasons. Mr. Huston joined Galapagos NV in 2023 from Kite Pharma, Inc., t...

 PRESS RELEASE

Galapagos kondigt het vertrek van haar CFO en COO, Thad Huston, aan pe...

Galapagos kondigt het vertrek van haar CFO en COO, Thad Huston, aan per 1 augustus 2025 Mechelen, België; 15 april 2025, 07:30 CET; gereglementeerde informatie - voorwetenschap – Galapagos NV (Euronext & NASDAQ: GLPG), een wereldwijd biotechnologiebedrijf dat zich toelegt op het transformeren van patiëntresultaten door middel van levensveranderende wetenschap en innovatie, heeft vandaag het vertrek van haar CFO en COO, Thad Huston, aangekondigd per 1 augustus 2025. De heer Huston heeft besloten om Galapagos te verlaten en terug te keren naar de U.S. voor persoonlijke en professionele rede...

 PRESS RELEASE

Weekly progress on share repurchase program to cover share plans and r...

Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), April 15, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total am...

Dirk Verbiesen ... (+2)
  • Dirk Verbiesen
  • Quirijn Mulder

Arcadis/Short-term challenges/HOLD (previously Buy)

Albeit for a service company like Arcadis the direct tariffs have a modest impact on the current business, we believe that the indirect impact is significant, also on top of already mounting troubles for the sector. Arcadis is not immune, we think. Decelerating growth for its net revenues, filtering through via operational leverage leads to material lower earnings estimates for FY25 with a recovery in FY26, but from a lower point. Also, given the slowdown, we think Arcadis' FY26 margin target wi...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

CM.com: Preview of 1Q25 trading update. dsm-firmenich: Frankly my dear, I don't Givaudan. Fagron: 1Q25 revenue beat, ambitious midterm targets. Randstad: Preview 1Q25F results due 23 April; consensus released

EXMAR NV: 1 director

A director at EXMAR NV bought 64,842 shares at 11.500EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

US Tariffs Navigating the impact on Benelux equities

Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.

 PRESS RELEASE

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of ...

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Press Release Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, is pleased to announce the appointment of Laetitia Pictet as Chief Legal, Risk and Compliance Officer (CLRCO), effective May 1, 2025. She succeeds Jane Sinclair, who is retiring after a distinguished career. Laetitia Pictet brings over 25 years of senior legal expertise across Europ...

 PRESS RELEASE

Weekly progress on share repurchase program to cover share plans and r...

Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total amo...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch